Off-patent Drug Library

Cat. No.: HY-L141: Library Contents: XLSX PDF SDF

Drug repurposing (also called drug repositioning, reprofiling, or re‑tasking) offers various advantages over developing an entirely new drug for a given indication, for example, lower risk of failure, less investment, and shorter development timelines. But drug repositioning projects are also subject to several risks, including regulatory and intellectual property issues. So the off-patent drugs are optimal for repositioning because of their immediate availability for clinical studies, with high feasibility and relatively low risk.

MCE carefully prepared a unique collection of 2550 off-patent drugs, which is a good choice for drug repurposing.

MCE Off-patent Drug Library can be supplied as pre-dissolved Solutions or Solid. For pre-dissolved solutions in this library, there are 2481 compounds supplied in 10 mM solution, 48 compounds supplied in 2 mM solution and 21 compounds supplied in 3 mg/mL solution.

For pre-dissolved solutions, 10 mM for compounds with the solubility not lower than 10 mM, 2 mM for compounds with solubility between 2 mM and 10 mM, and 3 mg/mL for compounds with unconfirmed molecular weight and solubility not lower than 3 mg/mL.

Size (Pre-dissolved Solution or Solid)	Price	Stock
30 μL/well Solution 10 mM , 2 mM and 3 mg/mL Pre-dissolved Solution	Get quote	In-stock
50 μL/well Solution 10 mM , 2 mM and 3 mg/mL Pre-dissolved Solution	Get quote	In-stock
100 μL/well Solution 10 mM , 2 mM and 3 mg/mL Pre-dissolved Solution	Get quote	In-stock
2 × 100 μL/well Solution 10 mM , 2 mM and 3 mg/mL Pre-dissolved Solution	Get quote	In-stock

Download Screening Library Catalog

Please contact us at

[email protected]

Publications Citing Use of MCE Compound Libraries

Description
Product Details
Documentation

Description & Advantages	• A unique collection of 2550 off-patent approved drugs that can be used for high throughput screening (HTS) and high content screening (HCS). • Used in the research of oncology, cardiology, anti-inflammatory, immunology, dermatology, endocrinology, neurology, and more. • A good choice for drug repurposing. • Structurally diverse, bioactive, and cell permeable. • More detailed compound information with structure, IC50, and brief introduction. • NMR and HPLC validated ensure high purity. • All compounds are in stock and continuously updated.
Product Details	Formulation: A collection of 2550 off-patent drugs supplied as pre-dissolved Solutions or Solid. Solution: 2481 compounds supplied in 10 mM solution, 48 compounds supplied in 2 mM solution, 21 compounds supplied in 3 mg/mL solution. Layout: 96-well storage tube or 96-well plate: 1st and 12th column are left empty. 384-well plate: the first two columns and the last two columns are left empty. Compounds with different concentrations or dissolved in different solvents will be put on separate plates. This way of layout may increase the number of plates because there could be three solvents and three concentrations. If you have other requirements, please let us know. Container: 96- or 384-well Plate with Peelable Foil Seal; 96-well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode. Storage: In solvent: -80°C 2 years, -20°C 1 year; Powder: -20°C 3 years, 4°C 2 years Shipping: Blue ice
Documentation	XLSX PDF Library Handling Instructions (351 KB)

Your Recently Viewed Products:

Product Name

Salutation

Applicant Name *

Email Address *

Phone Number *

Organization Name *

Department *

Requested quantity *

Country or Region *

Container *

Remarks

Name
Email *

	Sorry, but the email address you supplied was invalid.

Off-patent Drug Library

Publications Citing Use of MCE Compound Libraries

Description

Product Details

Documentation

Your Recently Viewed Products:

Request for SDF File

Request for SDF File